Metser, U.; Ortega, C.; Hussey, D.; Chan, R.; Berlin, A.; Finelli, A.; Veit-Haibach, P.
18F-DCFPyL (PSMA) PET in the Management of Men with Biochemical Failure after Primary Therapy: Initial Clinical Experience of an Academic Cancer Center. Curr. Oncol. 2021, 28, 3251-3258.
https://doi.org/10.3390/curroncol28050282
AMA Style
Metser U, Ortega C, Hussey D, Chan R, Berlin A, Finelli A, Veit-Haibach P.
18F-DCFPyL (PSMA) PET in the Management of Men with Biochemical Failure after Primary Therapy: Initial Clinical Experience of an Academic Cancer Center. Current Oncology. 2021; 28(5):3251-3258.
https://doi.org/10.3390/curroncol28050282
Chicago/Turabian Style
Metser, Ur, Claudia Ortega, Douglas Hussey, Rosanna Chan, Alejandro Berlin, Antonio Finelli, and Patrick Veit-Haibach.
2021. "18F-DCFPyL (PSMA) PET in the Management of Men with Biochemical Failure after Primary Therapy: Initial Clinical Experience of an Academic Cancer Center" Current Oncology 28, no. 5: 3251-3258.
https://doi.org/10.3390/curroncol28050282
APA Style
Metser, U., Ortega, C., Hussey, D., Chan, R., Berlin, A., Finelli, A., & Veit-Haibach, P.
(2021). 18F-DCFPyL (PSMA) PET in the Management of Men with Biochemical Failure after Primary Therapy: Initial Clinical Experience of an Academic Cancer Center. Current Oncology, 28(5), 3251-3258.
https://doi.org/10.3390/curroncol28050282
